These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 31489594

  • 1. Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
    Ciferska H, Honsova E, Lodererova A, Hruskova Z, Neprasova M, Vachek J, Suchanek M, Zima T, Coppo R, Tesar V, Novak J, Maixnerova D.
    J Nephrol; 2020 Apr; 33(2):307-316. PubMed ID: 31489594
    [Abstract] [Full Text] [Related]

  • 2. Different Expression Patterns of Toll-Like Receptor mRNAs in Blood Mononuclear Cells of IgA Nephropathy and IgA Vasculitis with Nephritis.
    Saito A, Komatsuda A, Kaga H, Sato R, Togashi M, Okuyama S, Wakui H, Takahashi N.
    Tohoku J Exp Med; 2016 Nov; 240(3):199-208. PubMed ID: 27818460
    [Abstract] [Full Text] [Related]

  • 3. Analysis of glomerular anionic charge status in children with IgA nephropathy using confocal laser scanning microscopy.
    Sakagami Y, Nakajima M, Takagawa K, Ueda T, Akazawa H, Maruhashi Y, Shimoyama H, Kamitsuji H, Yoshioka A.
    Nephron Clin Pract; 2004 Nov; 96(3):c96-104. PubMed ID: 15056992
    [Abstract] [Full Text] [Related]

  • 4. Correlation analysis between expression of histone deacetylase 6 and clinical parameters in IgA nephropathy patients.
    Hu Y, Shang M, Shi Y, Tao M, Yuan W, Tang L, Ma X, Cui B, Chen H, Zhou X, Zhuang S, Liu N.
    Ren Fail; 2021 Dec; 43(1):684-697. PubMed ID: 33896334
    [Abstract] [Full Text] [Related]

  • 5. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG, Araújo SA, Bambirra EA, Oliveira EA, Simões E Silva AC, Pinheiro SVB.
    J Pediatr (Rio J); 2017 Dec; 93(4):389-397. PubMed ID: 28130969
    [Abstract] [Full Text] [Related]

  • 6. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L, Benito A, Oviedo MV, López Del Moral Cuesta C, Martín López J, Gómez Román J, López-Mejías R, Fernandez-Fresnedo G, Ruíz San Millán JC, Rodrigo Calabia E.
    Nefrologia (Engl Ed); 2019 Dec; 39(5):523-530. PubMed ID: 30902505
    [Abstract] [Full Text] [Related]

  • 7. Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy.
    Cox SN, Chiurlia S, Divella C, Rossini M, Serino G, Bonomini M, Sirolli V, Aiello FB, Zaza G, Squarzoni I, Gangemi C, Stangou M, Papagianni A, Haas M, Schena FP.
    Sci Rep; 2020 Sep 16; 10(1):15164. PubMed ID: 32938960
    [Abstract] [Full Text] [Related]

  • 8. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž, Laurinavičius A, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    Medicina (Kaunas); 2016 Sep 16; 52(6):340-348. PubMed ID: 27932191
    [Abstract] [Full Text] [Related]

  • 9. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 10. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y, Liu JC, Xiao HJ, Huang JP, Yang JY.
    Zhonghua Er Ke Za Zhi; 2004 Jun 14; 42(6):412-6. PubMed ID: 15265422
    [Abstract] [Full Text] [Related]

  • 11. NLRC5: potential novel non-invasive biomarker for predicting and reflecting the progression of IgA nephritis.
    Chen Y, Li H, Xiao C, Zeng X, Xiao X, Zhou Q, Xiao P.
    J Transl Med; 2018 Nov 19; 16(1):317. PubMed ID: 30453994
    [Abstract] [Full Text] [Related]

  • 12. Expression of alpha5beta1 and alpha6beta1 integrins in IgA nephropathy (IgAN) with mild and severe proteinuria. An immunohistochemical study.
    Wagrowska-Danilewicz M, Danilewicz M.
    Int Urol Nephrol; 2004 Nov 19; 36(1):81-7. PubMed ID: 15338682
    [Abstract] [Full Text] [Related]

  • 13. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M, Turczyn A, Such A, Cichoń-Kawa K, Małdyk J, Miklaszewska M, Pietrzyk J, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Szczepańska M, Bieniaś B, Zajączkowska M, Pukajło-Marczyk A, Zwolińska D, Siniewicz-Luzeńczyk K, Tkaczyk M, Gadomska-Prokop K, Grenda R, Demkow U, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2016 Nov 19; 952():75-84. PubMed ID: 27573641
    [Abstract] [Full Text] [Related]

  • 14. Expression of renal vitamin D receptors and metabolizing enzymes in IgA nephropathy.
    Arapović A, Vukojević K, Glavina Durdov M, Benzon B, Šolić I, Racetin A, Jurić M, Čujić T, Kosović I, Lozić M, Borić Škaro D, Ljutić D, Saraga-Babić M, Simičić Majce A, Saraga M, Filipović N.
    Acta Histochem; 2021 Jul 19; 123(5):151740. PubMed ID: 34111685
    [Abstract] [Full Text] [Related]

  • 15. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study.
    Handa T, Kakita H, Tateishi Y, Endo T, Suzuki H, Katayama T, Tsukamoto T, Muso E.
    Clin Exp Nephrol; 2018 Oct 19; 22(5):1116-1127. PubMed ID: 29564665
    [Abstract] [Full Text] [Related]

  • 16. A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges.
    Gutiérrez E, Carvaca-Fontán F, Luzardo L, Morales E, Alonso M, Praga M.
    Nephron; 2020 Oct 19; 144(11):555-571. PubMed ID: 32818944
    [Abstract] [Full Text] [Related]

  • 17. Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy.
    Alvarado AS, Andeen NK, Brodsky S, Hinton A, Nadasdy T, Alpers CE, Blosser C, Najafian B, Rovin BH.
    Nephrol Dial Transplant; 2018 Jul 01; 33(7):1168-1175. PubMed ID: 28992348
    [Abstract] [Full Text] [Related]

  • 18. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.
    Shu D, Xu F, Su Z, Zhang J, Chen C, Zhang J, Ding X, Lv Y, Lin H, Huang P.
    BMC Nephrol; 2017 Jan 07; 18(1):11. PubMed ID: 28061828
    [Abstract] [Full Text] [Related]

  • 19. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
    Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X, Lv J, Wang Z, Ren H, Shen P, Wang W, Zhang H, Xie J, Chen N.
    J Transl Med; 2018 May 03; 16(1):115. PubMed ID: 29724226
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 May 03; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.